Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Caregivers | 14 | 2023 | 2241 | 1.850 |
Why?
|
Breast Neoplasms | 25 | 2024 | 20988 | 1.310 |
Why?
|
Medication Adherence | 11 | 2024 | 2174 | 1.270 |
Why?
|
Quality of Life | 29 | 2023 | 13347 | 1.030 |
Why?
|
Adaptation, Psychological | 14 | 2022 | 2629 | 0.990 |
Why?
|
Stress, Psychological | 14 | 2022 | 4488 | 0.960 |
Why?
|
Anxiety | 18 | 2022 | 4570 | 0.940 |
Why?
|
Depression | 23 | 2022 | 8132 | 0.940 |
Why?
|
Gastrointestinal Neoplasms | 7 | 2018 | 955 | 0.820 |
Why?
|
Telemedicine | 3 | 2023 | 3050 | 0.710 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2024 | 3514 | 0.670 |
Why?
|
Affect | 6 | 2019 | 1486 | 0.660 |
Why?
|
Self Efficacy | 2 | 2020 | 636 | 0.560 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2022 | 5672 | 0.540 |
Why?
|
Palliative Care | 8 | 2019 | 3592 | 0.480 |
Why?
|
Neoplasms | 13 | 2023 | 22131 | 0.440 |
Why?
|
Family | 3 | 2017 | 3193 | 0.400 |
Why?
|
Interpersonal Relations | 3 | 2017 | 1438 | 0.380 |
Why?
|
Glioma | 2 | 2022 | 3453 | 0.350 |
Why?
|
Social Support | 4 | 2017 | 2174 | 0.350 |
Why?
|
Fatigue | 4 | 2020 | 1550 | 0.340 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2024 | 1520 | 0.340 |
Why?
|
Lung Neoplasms | 7 | 2017 | 13382 | 0.330 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 3028 | 0.270 |
Why?
|
Middle Aged | 41 | 2024 | 220584 | 0.260 |
Why?
|
Female | 48 | 2024 | 392148 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2019 | 5319 | 0.240 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3451 | 0.230 |
Why?
|
Brain Neoplasms | 2 | 2023 | 9026 | 0.230 |
Why?
|
Humans | 58 | 2024 | 760617 | 0.220 |
Why?
|
Administration, Oral | 4 | 2020 | 4010 | 0.220 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8516 | 0.200 |
Why?
|
Inflammation | 3 | 2017 | 10760 | 0.200 |
Why?
|
Aged | 28 | 2020 | 169042 | 0.190 |
Why?
|
Leukocytes | 3 | 2017 | 2023 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10199 | 0.180 |
Why?
|
Mastectomy | 3 | 2022 | 1817 | 0.180 |
Why?
|
Adult | 25 | 2020 | 220969 | 0.150 |
Why?
|
Trauma, Nervous System | 1 | 2017 | 35 | 0.150 |
Why?
|
Florida | 2 | 2017 | 429 | 0.150 |
Why?
|
Arm | 1 | 2020 | 588 | 0.150 |
Why?
|
Psychotherapy | 2 | 2018 | 1648 | 0.140 |
Why?
|
Aged, 80 and over | 9 | 2020 | 58894 | 0.140 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 990 | 0.140 |
Why?
|
Drug Therapy | 1 | 2020 | 503 | 0.140 |
Why?
|
Reminder Systems | 1 | 2020 | 386 | 0.140 |
Why?
|
Postoperative Period | 2 | 2016 | 1813 | 0.130 |
Why?
|
Phytotherapy | 1 | 2008 | 296 | 0.130 |
Why?
|
Cancer Care Facilities | 2 | 2018 | 421 | 0.130 |
Why?
|
Nursing Staff, Hospital | 1 | 2019 | 348 | 0.130 |
Why?
|
Male | 27 | 2022 | 360358 | 0.130 |
Why?
|
Actigraphy | 1 | 2019 | 521 | 0.130 |
Why?
|
Patients | 1 | 2022 | 906 | 0.130 |
Why?
|
Pilot Projects | 2 | 2020 | 8618 | 0.130 |
Why?
|
Transcription, Genetic | 2 | 2016 | 7583 | 0.120 |
Why?
|
Neoplasm Staging | 7 | 2019 | 11116 | 0.120 |
Why?
|
Physical Fitness | 1 | 2019 | 743 | 0.120 |
Why?
|
Survivors | 3 | 2019 | 2372 | 0.120 |
Why?
|
Friends | 1 | 2015 | 148 | 0.120 |
Why?
|
Psychotherapy, Brief | 1 | 2015 | 118 | 0.110 |
Why?
|
Lymphedema | 1 | 2020 | 523 | 0.110 |
Why?
|
Family Health | 2 | 2016 | 1253 | 0.110 |
Why?
|
Relaxation Therapy | 1 | 2015 | 181 | 0.110 |
Why?
|
Motor Activity | 1 | 2013 | 2714 | 0.110 |
Why?
|
Spouses | 1 | 2015 | 283 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2021 | 5239 | 0.100 |
Why?
|
Mammaplasty | 1 | 2022 | 1232 | 0.100 |
Why?
|
Young Adult | 9 | 2020 | 59179 | 0.100 |
Why?
|
Self Report | 3 | 2020 | 3723 | 0.100 |
Why?
|
Resilience, Psychological | 2 | 2016 | 786 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2019 | 2423 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13635 | 0.090 |
Why?
|
Patient Selection | 1 | 2023 | 4237 | 0.090 |
Why?
|
Single-Blind Method | 3 | 2015 | 1575 | 0.090 |
Why?
|
Intracranial Hemorrhages | 1 | 2016 | 809 | 0.090 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1080 | 0.090 |
Why?
|
Patient Compliance | 1 | 2021 | 2688 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39063 | 0.090 |
Why?
|
Exercise Therapy | 1 | 2017 | 929 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2017 | 9277 | 0.090 |
Why?
|
Interleukin-1beta | 1 | 2016 | 998 | 0.090 |
Why?
|
Regression Analysis | 2 | 2018 | 6338 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1418 | 0.080 |
Why?
|
Patient Participation | 1 | 2017 | 1443 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1884 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9313 | 0.070 |
Why?
|
Massachusetts | 1 | 2021 | 8833 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7798 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2218 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5061 | 0.070 |
Why?
|
Research Design | 1 | 2023 | 6174 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11736 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2643 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2020 | 15612 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 4007 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2016 | 3206 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8542 | 0.060 |
Why?
|
Stroke | 2 | 2019 | 9712 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2020 | 64568 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3194 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2495 | 0.060 |
Why?
|
Health Expenditures | 1 | 2017 | 2361 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4341 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20074 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15828 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2019 | 4575 | 0.060 |
Why?
|
Critical Illness | 1 | 2016 | 2709 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8645 | 0.050 |
Why?
|
Genotype | 1 | 2017 | 12978 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4803 | 0.050 |
Why?
|
Exercise | 1 | 2017 | 5886 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7389 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 26049 | 0.040 |
Why?
|
Intensive Care Units | 3 | 2019 | 3742 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 74115 | 0.040 |
Why?
|
Santalaceae | 1 | 2008 | 1 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6826 | 0.040 |
Why?
|
Tumor Escape | 1 | 2011 | 371 | 0.040 |
Why?
|
Agaricales | 1 | 2008 | 30 | 0.040 |
Why?
|
Schizophrenia | 1 | 2017 | 6929 | 0.040 |
Why?
|
Emotions | 2 | 2023 | 2740 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2020 | 673 | 0.040 |
Why?
|
Disease Management | 2 | 2020 | 2506 | 0.040 |
Why?
|
Body Image | 1 | 2022 | 639 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6807 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2011 | 1437 | 0.030 |
Why?
|
Immunity | 1 | 2011 | 994 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
United States | 2 | 2021 | 72272 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2017 | 596 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 632 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29600 | 0.030 |
Why?
|
Anger | 1 | 2016 | 406 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 778 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9417 | 0.030 |
Why?
|
Self Care | 1 | 2019 | 796 | 0.030 |
Why?
|
Focus Groups | 1 | 2019 | 1409 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2023 | 1447 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2326 | 0.030 |
Why?
|
Chemokines | 1 | 2017 | 954 | 0.030 |
Why?
|
Prospective Studies | 3 | 2022 | 54360 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2017 | 905 | 0.020 |
Why?
|
Neurosciences | 1 | 2016 | 367 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1504 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4037 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2019 | 80566 | 0.020 |
Why?
|
Time Factors | 2 | 2017 | 39913 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3777 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2315 | 0.020 |
Why?
|
Qualitative Research | 1 | 2019 | 3016 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9643 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6016 | 0.020 |
Why?
|
Psychometrics | 1 | 2016 | 3060 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5866 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4910 | 0.020 |
Why?
|
Cause of Death | 1 | 2015 | 3683 | 0.020 |
Why?
|
Health Status | 1 | 2017 | 4075 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3066 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13495 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 12661 | 0.010 |
Why?
|
Mental Health | 1 | 2016 | 3251 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7373 | 0.010 |
Why?
|
Child | 2 | 2021 | 80079 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3351 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10505 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12447 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 88234 | 0.010 |
Why?
|
Cognition | 1 | 2015 | 6987 | 0.010 |
Why?
|
Body Mass Index | 1 | 2016 | 12943 | 0.010 |
Why?
|
Animals | 1 | 2008 | 168201 | 0.000 |
Why?
|
Concepts
(170)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_